Pure Bioscience, Inc. (PURE) Reports Q3 Loss of $0.04/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- Wall St set for muted open as tech wobble persists; Tesla gains
- Oil heads for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Join SI Premium – FREE
Pure Bioscience, Inc. (NASDAQ: PURE) reported Q3 EPS of ($0.04), versus ($0.05) reported last year. Revenue for the quarter came in at $207 thousand, versus $128 million reported last year.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Williams Trading Downgrades Birkenstock Holding plc (BIRK) to Sell, 'Stock Less Comfortable than the Shoes'
- H.C. Wainwright Reiterates Buy Rating on Humacyte (HUMA)
- BMO: 'We view the readthrough as modestly positive for CVSA/STRA'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
